Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk

This publication has 39 references indexed in Scilit:

• Association of lipoprotein subclass distribution with use of selective and non-selective beta-blocker medications in patients with coronary heart disease
  Atherosclerosis, 1993
• Differentiation of β-blocker effects on serum lipids and apolipoproteins in hypertensive patients with normolipidaemic or dyslipidaemic profiles
  European Heart Journal, 1992
• Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials
  European Heart Journal, 1992
• Beta-Blockers Versus Diuretics in Hypertensive Men: Main Results from the HAPPHY Trial
  Journal Of Hypertension, 1987
• Randomised trial of treatment of hypertension in elderly patients in primary care.
  BMJ, 1986
• Cardiovascular Risk and Risk Factors in a Randomized Trial of Treatment Based on the Beta-Blocker Oxprenolol: The International Prospective Primary Prevention Study in Hypertension (IPPPSH)
  Journal Of Hypertension, 1985
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.
  BMJ, 1985
• Prognostic factors in the treatment of mild hypertension. The Management Committee of the Australian National Blood Pressure Study.
  Circulation, 1984
• Treatment of mild hypertension: A five year controlled drug trial
  The American Journal of Medicine, 1980
• Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg
  Published by American Medical Association (AMA) ,1970